Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts

  • EdinG
    replied
    Detecting Shape Changes in ChIP-Seq data

    Hi,

    we have just added a new package called MMDiff to the latest Bioconductor release.
    It's a statistical testing method specifically designed to compare ChIP-Seq data sets. It takes advantage of higher order features to detect shape changes in ChIP-Seq peaks and should also be applicable to other -Seq methods, like DNase-Seq. Biological replicates are used to estimate biological variance.

    Here is the link to the package:

    The Bioconductor project aims to develop and share open source software for precise and repeatable analysis of biological data. We foster an inclusive and collaborative community of developers and data scientists.

    Leave a comment:


  • asiangg
    replied
    UPDATE: We have developed diffReps to detect differential chromatin modification sites from two groups of comparing ChIP-seq data.



    It takes into account of biological replicates. It bins the genome, calculates counts, normalizes by linear scaling, performs statistical tests and adjusts p-values. It does all of these in one command line. I hope people may find it to be useful!

    I'm not sure if we'll publish it in a paper. But I just want to share it with the community as an open source software.

    Leave a comment:


  • hongbo919
    replied
    Originally posted by mudshark View Post
    hi! unfortunately your server seems incredibly slow. i did not manage to download the standalone version. in addition, it would be nice to get some information on how your software works. do you have this documentation online, or published?
    Hi. Thanks for your test. You can try http://202.97.205.78/epidiff/ for the EpiDiff. In addtion, the paper of this tool is under review and has not been published. However, there are detailed tutorials which can be found easily in the website . The turorials will tell you how this software works.
    Best wishes!
    Last edited by hongbo919; 02-17-2012, 11:22 PM.

    Leave a comment:


  • mudshark
    replied
    Originally posted by hongbo919 View Post
    Recently, we developed a tool EpiDiff including a professional tool QDCMR for identification of differential histone modifications.
    The software of EpiDiff is available at http://bioinfo.hrbmu.edu.cn/epidiff/. Look forward to you for testing this software and helping us to improve the software.
    hi! unfortunately your server seems incredibly slow. i did not manage to download the standalone version. in addition, it would be nice to get some information on how your software works. do you have this documentation online, or published?

    Leave a comment:


  • hongbo919
    replied
    A professional tool for identification of differential histone modifications

    Recently, we developed a tool EpiDiff including a professional tool QDCMR for identification of differential histone modifications.
    The software of EpiDiff is available at http://bioinfo.hrbmu.edu.cn/epidiff/. Look forward to you for testing this software and helping us to improve the software.

    Leave a comment:


  • biznatch
    replied
    Ah ok I understand. So if there is a real biological increase in your histone at/near the TSS then I think you could be expected to see a decrease in the background. Eg. if you do 10 million reads of each sample, and one sample has lots of peaks at TSS then the TSS reads will take away from the background reads.

    I guess this is why it's hard to quantitatively compare samples that have large differences in peaks. The sample with lots more peaks will appear to have less background so normalising to (local) background levels may not be accurate. Maybe come combination of normalising to total number of reads and local background...have to keep thinking about it...

    In your case I'd say a western is probably a good way to determine if it's a real biological increase. And/or check a few sites by ChIP-qPCR.

    Leave a comment:


  • AdamB
    replied
    I mean there is an enrichment of reads at the regions surrounding the TSS, relative to the rest of the genome. One sample isn't consistently increased across the whole genome, since I'm normalising to total reads (to account for sequencing depth) for this comparison.

    If I count the reads across regions at least 10 kb away from genes (i.e. to find regions of predominantly background) the sample that has more reads surrounding the TSS has less reads in these regions. This suggests there is higher signal:background in this sample, due to either a real biological difference, or difference in ChIP enrichment levels.

    Leave a comment:


  • biznatch
    replied
    Adam, just to be sure I understand, you find the same number of reads between samples at TSS ±2 kb, what region are you referring to that you see a definite difference? Do you mean that in the local region around the ±2 kb, like, within 100kb, you see a difference, or do you mean one sample is increased across the entire genome?

    Leave a comment:


  • Simon Anders
    replied
    Adam: Each column of the count table gets a normalization factor. The table has one column for each ChIP sample. The input sample does not enter the count table. This is what I meant by saying that the input should only be used for finding the peaks, not for comparing them.

    Leave a comment:


  • AdamB
    replied
    @Simon Anders
    Would DESeq apply linear scaling between treatments (rather than between sample X and input X)? Please can you elaborate more on what you would like to see in a scatter plot? Also, are replicates required or can two individual samples be compared?

    @biznatch
    If I plot the number of aligned reads at TSS ±2 kb, my treatments look similar, but there is a definite difference across the region - one treatment is higher. I'm unsure whether this is a real global difference in H3ac (its possible my treatment could induce such an effect), or due to biological/technical variation. I guess the only way to determine this for sure would be with a Western blot?
    Last edited by AdamB; 04-11-2011, 10:28 AM.

    Leave a comment:


  • biznatch
    replied
    For input, SISSRS considers our input sample before calling peaks so any "false" peaks shouldn't even be called. Though as Simon said, when looking for changes between treatments, false peaks shouldn't be changed so it probably isn't much of an issue.

    In regards to normalising between samples (treated and untreated), in this case, they have nearly identical number of reads and number of peaks so it's not an issue, we also plan to validate sites by ChIP-PCR. But it is something I've thought of for future experiments, I've tried looking online but haven't found any consensus on what to do.

    What if normalisation is done for each peak comparison individually? Ie. look at the 500bp up and downstream of the peak, determine average height, compare between samples and scale one of the samples linearly, as needed? Would this account for both changes in overall sequencing depth and variability in particular regions of the genome?

    Leave a comment:


  • mudshark
    replied
    Hi Simon. RNASeq does/might not suffer from oversampling but ChIPSeq does. Oversampling appears to happen in particular in regions of high DNAse sensitivity, i.e. promoters and regulatory regions. That's probably due to a preferential release of sequencer-preferred-size fragments there. While transcribed sequences are under-sampled. All tested using qPCR.

    Leave a comment:


  • Simon Anders
    replied
    In an RNA-Seq context, this is no problem at all; DESeq and edgeR are designed to handle this implicitly. I'm not sure what you mean by oversampling, but I guess it is nothing that happens in RNA-Seq. There, you may get pretty uneven coverage across a gene, but if you look at tracks for two replicates, even if they have different depth, everything scales nicely and linearly (except for the shot noise, of course, which scales with the square root).

    Leave a comment:


  • mudshark
    replied
    sorry guys: when I mentioned "big difference in sequencing depth" I tried to refer to an experimental scenario that happened to me more than once: varying sequencing depth based on technical problems (e.g. very uneven read distribution in a multiplex run). Just as an example 5 Mio reads in control IP versus 10 Mio reads in treatment IP. I personally consider this impossible to analyze (in a ChIPSeq expt)

    Of course there might be variation before library preparation. However, biological effects in chromatin are frequently rather mild, therefore I do more fear the technical variations. Still, any biological variation has also be considered.

    Leave a comment:


  • AdamB
    replied
    @mudshark

    When you say 'difference in sequencing depth', do you mean technical variation arising somewhere between the library construction and obtaining mapped reads? Because my other point was that variation could also arise before library construction, from differences in ChIP enrichment between samples. Any normalisation would need to take into account both of these sources of variation.

    Leave a comment:

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2





    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification,...
    10-30-2026, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 07:59 AM
0 responses
13 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 11-05-2026, 09:25 AM
0 responses
32 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 11-03-2026, 11:54 AM
0 responses
45 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
171 views
0 reactions
Last Post SEQadmin2  
Working...